BRINGING BITES BEYOND THE BEDSIDE IMPLEMENTING SAFE OUTPATIENT STEP-UP DOSING FOR MULTIPLE MYELOMA.
Significance & Background: Bispecific T-cell Engagers (BiTEs) are immunotherapies that link T-cells to specific cancers. Two primary adverse events associated with BiTEs are cytokine release syndrome (CRS) and neurotoxicity. Due to these risks, package inserts recommend inpatient monitoring for 48 h...
| Publicado en: | Oncology Nursing Forum Vol. 53; no. 2; pp. 106 - 108 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
Oncology Nursing Society
Mar2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |